139 related articles for article (PubMed ID: 11241016)
1. Potential clinical efficacy and cost benefit of a transesophageal echocardiography-guided low-molecular-weight heparin (enoxaparin) approach to antithrombotic therapy in patients undergoing immediate cardioversion from atrial fibrillation.
Murray RD; Deitcher SR; Shah A; Jasper SE; Bashir M; Grimm RA; Klein AL
J Am Soc Echocardiogr; 2001 Mar; 14(3):200-8. PubMed ID: 11241016
[TBL] [Abstract][Full Text] [Related]
2. Transesophageal echocardiography guided enoxaparin antithrombotic strategy for cardioversion of atrial fibrillation: the ACUTE II pilot study.
Murray RD; Shah A; Jasper SE; Goodman A; Deitcher SR; Katz WE; Malouf JF; Stoddard MF; Grimm RA; Klein AL;
Am Heart J; 2000 Jun; 139(6):E1-7. PubMed ID: 10827367
[TBL] [Abstract][Full Text] [Related]
3. Economic evaluation of enoxaparin for anticoagulation in early cardioversion of persisting nonvalvular atrial fibrillation: a statutory health insurance perspective from Germany.
Schädlich PK; Schmidt-Lucke C; Huppertz E; Lehmacher W; Nixdorff U; Stellbrink C; Brecht JG
Am J Cardiovasc Drugs; 2007; 7(3):199-217. PubMed ID: 17610347
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of transesophageal echocardiographic-guided cardioversion: a decision analytic model for patients admitted to the hospital with atrial fibrillation.
Seto TB; Taira DA; Tsevat J; Manning WJ
J Am Coll Cardiol; 1997 Jan; 29(1):122-30. PubMed ID: 8996304
[TBL] [Abstract][Full Text] [Related]
5. Economic analysis of a transesophageal echocardiography-guided approach to cardioversion of patients with atrial fibrillation: the ACUTE economic data at eight weeks.
Klein AL; Murray RD; Becker ER; Culler SD; Weintraub WS; Jasper SE; Lieber EA; Apperson-Hansen C; Heerey AM; Grimm RA;
J Am Coll Cardiol; 2004 Apr; 43(7):1217-24. PubMed ID: 15063433
[TBL] [Abstract][Full Text] [Related]
6. Cost in the use of enoxaparin compared with unfractionated heparin in patients with atrial fibrillation undergoing a transesophageal echocardiography-guided cardioversion (from Assessment of Cardioversion using Transesophageal Echocardiography [ACUTE] II randomized multicenter study).
Zhao L; Zhang Z; Kolm P; Jasper S; Lewis C; Klein A; Weintraub W;
Am J Cardiol; 2008 Feb; 101(3):338-42. PubMed ID: 18237596
[TBL] [Abstract][Full Text] [Related]
7. Post-cardioversion transesophageal echocardiography (POSTEC) strategy with the use of enoxaparin for brief anticoagulation in atrial fibrillation patients: the multicenter POSTEC trial (a pilot study).
Sorino M; Colonna P; De Luca L; Carerj S; Oliva E; De Tommasi SM; Conti U; Iacopi F; D'Agostino C; D'Amato N; Pettinati G; Montericcio V; Cualbu A; De Luca I
J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1034-42. PubMed ID: 18163016
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
[TBL] [Abstract][Full Text] [Related]
9. Pre- and post-cardioversion transesophageal echocardiography for brief anticoagulation therapy with enoxaparin in atrial fibrillation patients: a prospective study with a 1-year follow-up.
de Luca I; Sorino M; De Luca L; Colonna P; Del Salvatore B; Corlianò L
Int J Cardiol; 2005 Jul; 102(3):447-54. PubMed ID: 16004890
[TBL] [Abstract][Full Text] [Related]
10. The use of enoxaparin compared with unfractionated heparin for short-term antithrombotic therapy in atrial fibrillation patients undergoing transoesophageal echocardiography-guided cardioversion: assessment of Cardioversion Using Transoesophageal Echocardiography (ACUTE) II randomized multicentre study.
Klein AL; Jasper SE; Katz WE; Malouf JF; Pape LA; Stoddard MF; Apperson-Hansen C; Lieber EA;
Eur Heart J; 2006 Dec; 27(23):2858-65. PubMed ID: 17098762
[TBL] [Abstract][Full Text] [Related]
11. Health status outcomes after cardioversion for atrial fibrillation: results from the Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) II Trial.
Elliott DJ; Zhao L; Jasper SE; Lieber EA; Klein AL; Weintraub WS
Am Heart J; 2008 Aug; 156(2):374.e1-6. PubMed ID: 18657673
[TBL] [Abstract][Full Text] [Related]
12. Comparing TEE- vs Non-TEE-guided cardioversion of atrial fibrillation: The ENSURE-AF trial.
Kozieł M; Merino JL; De Caterina R; Huber K; Jin J; Melino M; Goette A; Lip GYH;
Eur J Clin Invest; 2020 May; 50(5):e13221. PubMed ID: 32150758
[TBL] [Abstract][Full Text] [Related]
13. Cardioversion in patients with atrial fibrillation and left atrial thrombi on initial transesophageal echocardiography: should transesophageal echocardiography be repeated before elective cardioversion? A cost-effectiveness analysis.
Seto TB; Taira DA; Manning WJ
J Am Soc Echocardiogr; 1999 Jun; 12(6):508-16. PubMed ID: 10359923
[TBL] [Abstract][Full Text] [Related]
14. A new therapeutic strategy for electrical cardioversion of atrial fibrillation.
de Luca I; Sorino M; Del Salvatore B; de Luca L
Ital Heart J; 2001 Nov; 2(11):831-40. PubMed ID: 11770868
[TBL] [Abstract][Full Text] [Related]
15. Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial.
Goette A; Merino JL; Ezekowitz MD; Zamoryakhin D; Melino M; Jin J; Mercuri MF; Grosso MA; Fernandez V; Al-Saady N; Pelekh N; Merkely B; Zenin S; Kushnir M; Spinar J; Batushkin V; de Groot JR; Lip GY;
Lancet; 2016 Oct; 388(10055):1995-2003. PubMed ID: 27590218
[TBL] [Abstract][Full Text] [Related]
16. Safety of expedited anticoagulation in patients undergoing transesophageal echocardiographic-guided cardioversion.
Wu LA; Chandrasekaran K; Friedman PA; Ammash NM; Ramakrishna G; Hart CY; Moon BS; Herges RM; Rosales AG; Malouf JF
Am J Med; 2006 Feb; 119(2):142-6. PubMed ID: 16443416
[TBL] [Abstract][Full Text] [Related]
17. Cardioversion under the guidance of transesophageal echochardiograhy in persistent atrial fibrillation: results with low molecular weight heparin.
Akdeniz B; Türker S; Oztürk V; Badak O; Okan T; Aslan O; Kozan O; Kirimli O; Aytekin D; Bariş N; Güneri S
Int J Cardiol; 2005 Jan; 98(1):49-55. PubMed ID: 15676166
[TBL] [Abstract][Full Text] [Related]
18. Comparison of anticoagulant and anti-inflammatory responses using enoxaparin versus unfractionated heparin for transesophageal echocardiography-guided cardioversion of atrial fibrillation.
Hoppensteadt D; Fareed J; Klein AL; Jasper SE; Apperson-Hansen C; Lieber EA; Katz WE; Malouf JF; Stoddard MF; Pape LA;
Am J Cardiol; 2008 Oct; 102(7):842-6. PubMed ID: 18805108
[TBL] [Abstract][Full Text] [Related]
19. Transesophageal echocardiography-guided cardioversion of atrial fibrillation. Selection of a low-risk group for immediate cardioversion.
Fonseca N; Caetano F; Santos J; Seixo F; Bernardino L; Silvestre I; Cardoso P; Segurado F; Inês L
Rev Port Cardiol; 2004 Mar; 23(3):365-75. PubMed ID: 15185562
[TBL] [Abstract][Full Text] [Related]
20. Design of a clinical trial for the assessment of cardioversion using transesophageal echocardiography (The ACUTE Multicenter Study). Steering and Publications Committees of the ACUTE Study.
Am J Cardiol; 1998 Apr; 81(7):877-83. PubMed ID: 9555778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
